RxDoctor Payments Data

Sandra Wittholz

Women's Health · Atlanta, GANPI 1508847799

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 58 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 13.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $386 and has fallen 88.1% since, to $46 in 2025.

$1,098in general payments, 2019–2025

Across 58 payments — averaging $18.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Therapeuticsmd, Inc.$150
  • AbbVie$135
  • Daiichi Sankyo Inc.$102
  • Bayer$91
  • Sumitomo Pharma America, Inc.$91
  • Astellas Pharma US Inc$86
  • plus $443 from 16 others

What the payments were for

  • Food & beverage$1,098100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,098 in reported general payments places this provider in the 75th percentile of 247 women's health providers in Georgia.

See all women's health providers in Georgia

Medicare billing

Part B allowed, 2024
$9,180
Medicare patients
55
Services billed
271

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol21$1,261

Paid to pharmacies, not to this prescriber.

Other women's health in Atlanta

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →